Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Isala
University Health Network, Toronto
Murdoch Childrens Research Institute
Rigel Pharmaceuticals
AstraZeneca
University Hospital, Rouen
University of Florida
Aristotle University Of Thessaloniki
Brigham and Women's Hospital
Centre Hospitalier Régional d'Orléans
University Health Network, Toronto
Tanta University
University of Wisconsin, Madison
Chongqing University Cancer Hospital
Brigham and Women's Hospital
Air Liquide Santé International
University of Miami
Assistance Publique - Hôpitaux de Paris
GT Medical Technologies, Inc.
Ottawa Hospital Research Institute
GT Medical Technologies, Inc.
University Hospital, Strasbourg, France
Kyoto University, Graduate School of Medicine
University Health Network, Toronto
VA Greater Los Angeles Healthcare System
Amsterdam UMC, location VUmc
Tanta University
Monash University
University of Kentucky
Region Jönköping County
RECORDATI GROUP
Erasmus Medical Center
Chang Gung Memorial Hospital
Centre Hospitalier Universitaire Vaudois
Hospital Sirio-Libanes
Radboud University Medical Center
University Medical Center Groningen
Pfizer
University Hospital, Linkoeping
Beth Israel Deaconess Medical Center
Jules Bordet Institute
Kyoto University, Graduate School of Medicine
Mayo Clinic
Danone Specialized Nutrition
University of Sao Paulo
Birmingham Women's and Children's NHS Foundation Trust
Xinjiang Medical University
Oregon Health and Science University
Gruppo Oncologico Italiano di Ricerca Clinica